Philippe Van Trappen

Prof. Dr. Philippe Van Trappen

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
IVIgnace Vergote
Ignace Vergote
JMJavier F. MAGRINA
Javier F. MAGRINA
VZVanna Zanagnolo
Vanna Zanagnolo
PMPaul M. Magtibay
Paul M. Magtibay
KBKristina Butler
Kristina Butler
Philippe Van TrappenPhilippe Van Trappen
Philippe Van Trappen

5 October 2023 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
YBYasnaia Bruneel
Yasnaia Bruneel
CGChristophe Ghysel
Christophe Ghysel
CHCaroline Van Holsbeke
Caroline Van Holsbeke
Philippe Van TrappenPhilippe Van Trappen
Philippe Van Trappen
The application of indocyanine green (ICG) has recently been reported to aid in the resection of endometriosis in the bladder wall and/or involving the ureters. A symptomatic 41-year-old patient with dysmenorrhea and pollakisuria was referred to our tertiary center. Imaging revealed a 1.5–2 cm intramural endometriotic nodule in the posterior bladder wall. She was planned for robotic resection of the endometriotic nodule, under ICG guidance, together with a hysterectomy. After placement of double-J ureteral stents and clamping the bladder, perforation of the bladder mucosa could be avoided whilst performing a circumferential resection of the nodule. By clamping the bladder catheter after instillation of ICG, both the bladder wall thickness and ureters could be visualized with near-infrared imaging during robotic resection of the endometriotic nodule and hysterectomy. With the surgical approach described here, endometriotic nodules/tissue can be removed precisely with enlarged vision at the robot console, safely, and completely without damaging adjacent tissues.

7 November 2022 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
Philippe Van TrappenPhilippe Van Trappen
Philippe Van Trappen
ECEveline de Cuypere
Eveline de Cuypere
NCNele Claes
Nele Claes

Verified
Journal Article
Open access
PDF file
Philippe Van TrappenPhilippe Van Trappen
Philippe Van Trappen
MWMarie-Sofie Walgraeve
Marie-Sofie Walgraeve
SRSarah Roels
Sarah Roels
NCNele Claes
Nele Claes
ECEveline De Cuypere
Eveline De Cuypere
HAHarm Arentsen
Harm Arentsen
Background: Patients with persistent or recurrent cervical cancer, following primary treatment with concurrent chemoradiation, represent a subgroup eligible for pelvic exenteration. In light of the substantial morbidity associated with open pelvic exenterations, minimally invasive surgical techniques have been introduced. This systematic review aims to analyze and discuss the current literature on robotic-assisted pelvic exenterations in cervical cancer. In addition, novel aspects of compartment-based magnetic resonance imaging (MRI) are highlighted. Methods: This systematic review followed the PRISMA guidelines, and a comprehensive literature search on robotic-assisted pelvic exenterations in cervical cancer was conducted to assess, as main objectives, early and late postoperative complications as well as oncological outcomes. Inclusion and exclusion criteria were applied to select eligible studies. Results: Among the reported cases of robotic-assisted pelvic exenterations in cervical cancer, 79.4% are anterior pelvic exenterations. Intraoperative complications are minimal and early/late major complications averaged between 30–35%, which is lower compared to open pelvic exenterations. Oncological outcomes are similar between robotic and open pelvic exenterations. Sensitivity for locoregional invasion increases up to 93% for compartment-based MRI in colorectal cancer. A refined delineation of the seven pelvic compartments for cervical cancer is proposed here. Conclusions: Robotic-assisted pelvic exenterations have demonstrated feasibility and safety, with reduced rates of major complications compared to open surgery, while maintaining surgical efficiency and oncological outcomes. Compartment-based MRI holds promise for standardizing the selection and categorization of pelvic exenteration procedures.

16 October 2021 in The International Journal of Medical Robotics and Computer Assisted Surgery
Verified
Journal Article
Closed access
PDF file
SDSander Dumont
Sander Dumont
Philippe Van TrappenPhilippe Van Trappen
Philippe Van Trappen

29 January 2022 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
CDCharlotte Delrue
Charlotte Delrue
LVLieve Vanwalleghem
Lieve Vanwalleghem
PPPascale DE Paepe
Pascale DE Paepe
Philippe Van TrappenPhilippe Van Trappen
Philippe Van Trappen
Background: This report discusses the current literature on both non-invasive and invasive SMILE ((i)SMILE) lesions of the cervix with focus on the pathology and its related clinical diversity in several cases. Currently, the knowledge on (i)SMILE is limited to single case reports and series. As a consequence, consensus guidelines regarding the management are lacking. Although there is overlap with both high grade squamous intra-epithelial lesion (HSIL) and adenocarcinoma in situ (AIS) on immunohistochemical analyses, it is recommended to treat SMILE like AIS and further excision is needed when surgical margins are positive for SMILE on conization. (i)SMILE, should be considered as a rare subtype of adenocarcinoma of the cervix, and should be treated as such. Case Report: We describe a case with a SMILE lesion undergoing a subsequent robotic hysterectomy after conization and two cases with iSMILE: one case with an early FIGO-stage 1B1 iSMILE tumor, undergoing a robotic radical hysterectomy with sentinel procedure, and one case undergoing a robotic-assisted pelvic/para-aortic lymph node staging dissection, confirming a metastatic FIGO-stage 3C2 (for primary chemo-radiotherapy treatment). Conclusion: Here, we report for the first time a few cases of (i)SMILE with different clinical presentations, their management and follow-up. Immunohistochemical characteristics are given for both primary lesions as well as the metastases.